Weekly Market Update: value stocks lead market rally on positive vaccine news

Market Update

Global equities rose +0.4% in local currency terms, although currency movements eroded this gain for British investors, leaving global equities down -0.2% in Sterling terms. Equities were once again supported by vaccine news, with Moderna’s vaccine showing similar levels of efficacy to the already announced Pfizer data. European equities rose for the third consecutive week, up +0.7% in sterling terms. UK equities were up +0.6% for the week as the strong growth of the previous fortnight began to moderate. Globally the best performing sectors were once again Energy and Financials. The worst performing sectors were Utilities and Healthcare. Yields fell for both credit and government bonds last week; the UK 10 year fell to 0.302% and its US counterpart to 0.842%, while yields fell significantly in high yield credit markets. Oil prices rose +4.3% to $42.7 a barrel on the positive vaccine news. Gold fell -1.6% to $1,875 per Troy ounce.

CIO analysis

Markets spent another week near all-time highs coming out of an earnings season where companies outperformed expectations while good news about vaccines and the end (?) of the US election further contributed to market buoyancy. Tactically, virus risks ahead are still too significant to ignore and it would appear that reality is still miles behind expectations – and valuations. Experts note that even if vaccines are fully approved and distribution begins by early January, the time it will take for a meaningful portion of the population to be vaccinated, plus the 30-day period before the vaccine has actually produced an able quantity of antibodies, means that economic conditions, for certain industries at least, will still remain challenging throughout the winter. And, currently, there is still no evidence as to how long vaccine-immunity might last. However markets at this point are less likely to react to potential bad economic data without considering mitigating factors to that data, such as fiscal and monetary stimulus. Thus, in the UK, we would not be too surprised if furlough schemes and other targeted measures were extended even beyond March, especially as Brexit could add further to economic pressures. In the US, where on Friday the Treasury Secretary unexpectedly decided to remove some emergency fiscal safety nets available to the Fed by the end of the year (over the US Central Bank’s rare vocal objection), investors may still take comfort in the idea that this is a play we have seen before, and that it worked out well for risk assets. In 2008, as Democrats and Republicans argued bitterly over fiscal stimulus 45 days ahead of the presidential election, the Fed was thrusted into a nearly unprecedented “whatever it takes mode”, eventually capping losses and jump-starting a stock and bond rebound which, arguably, has lasted to this day. The lesson here is that investors should not focus singularly on Covid-19 news, but should rather consider them in conjunction with fiscal and monetary measures taken to counter the economic effects of the virus. If these are deemed sufficient by portfolio managers, then risks for portfolios are not as great as they might seem. If questions around the efficacy of the measures linger, then more defensive approaches are probably warranted. Currently we stand in the camp of “sufficient – but with thin safety margins and possibly extended”. -David Baker, CIO

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *